Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
– Dr. Petit is a well-established C-suite life sciences executive and innovative inventor/scientist with a primary focus as an immunologist in all medical and scientific aspects of pharmaceutical...
-
NORTHBROOK, Ill., July 31, 2018 (GLOBE NEWSWIRE) -- Immunomodulation Inc. ("Immunomodulation" or the "Company"), a privately-held biopharmaceutical company focused on developing breakthrough...
-
Company Offers Corporate Overview and 2018 Business Outlook NORTHBROOK, Ill., May 30, 2018 (GLOBE NEWSWIRE) -- Immunomodulation Inc. ("Immunomodulation" or the "Company"), a privately-held...